Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21075438 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel;   Radiation: LDWART (Low Dose Whole Abdominal Radiation Therapy)
2 Recruiting Study of Low-Dose Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Radiation: Low dose whole liver and portal lymph node basin radiotherapy

Indicates status has not been verified in more than two years